Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Asia Pharma ExpoAsia Pharma Expo
Not Confirmed
Not Confirmed
29-31 March, 2026
Bio-Europe SpringBio-Europe Spring
Not Confirmed
Not Confirmed
31 March-01 April, 2026
Nutri Ingredients Summ...Nutri Ingredients Summit
Not Confirmed
Not Confirmed
31 March-01 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Asia Pharma ExpoAsia Pharma Expo
Industry Trade Show
Not Confirmed
29-31 March, 2026
Bio-Europe SpringBio-Europe Spring
Industry Trade Show
Not Confirmed
31 March-01 April, 2026
Nutri Ingredients Summ...Nutri Ingredients Summit
Industry Trade Show
Not Confirmed
31 March-01 April, 2026
Digital content

10 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/10/3252886/0/en/Arcutis-Announces-Publication-of-Positive-Long-Term-Safety-and-Efficacy-Data-with-ZORYVE-roflumilast-Cream-0-05-for-Treatment-of-Mild-to-Moderate-Atopic-Dermatitis-in-Children-Ages.html

03 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/03/3248270/0/en/Arcutis-Begins-Enrolling-Phase-1a-1b-Study-Evaluating-ARQ-234-a-CD200R-Agonist-in-Healthy-Volunteers-and-Adults-With-Atopic-Dermatitis.html

27 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/27/3246782/0/en/Arcutis-Management-to-Present-at-TD-Cowen-s-46th-Annual-Health-Care-Conference.html

25 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/25/3244953/0/en/Arcutis-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

05 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/05/3233407/0/en/Arcutis-Biotherapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

02 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/02/3230196/0/en/Arcutis-Announces-Positive-Topline-Results-for-INTEGUMENT-INFANT-Phase-2-Trial-of-ZORYVE-roflumilast-Cream-0-05-in-Infants-with-Mild-to-Moderate-Atopic-Dermatitis.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE